Lincoln International (LCLN) GC Marvin Kristin Marie Receives Awards

What happened Marvin Kristin Marie, General Counsel of Lincoln International, was granted multiple equity awards reported on a Form 4 filed May 26, 2026. The filing shows grants totaling 186,200 units across several transactions: 79,950 shares (May 19, 2026), 25,000 Class A shares (May 21, 2026), and derivative awards including one RSU grant of 20,800 and three option-type derivative grants of 20,150 each (all reported May 19, 2026). All grants are reported at $0.00 (no cash purchase); these are awards/compensation, not open-market purchases or sales.

Key details

• Transaction dates and amounts:
  • 2026-05-19: 79,950 shares acquired (pre-registration grant; see F1)
  • 2026-05-21: 25,000 shares acquired @ $0.00 (reorganization-related; see F2)
  • 2026-05-19: 20,800 RSUs @ $0.00 (derivative; see F3)
  • 2026-05-19: three derivative awards of 20,150 each @ $0.00 (listed as derivative grants; see F4–F7)
• Total units granted: 186,200 (mix of Class A shares, RSUs and stock options/derivatives).
• Shares owned after transaction: not provided in the excerpt.
• Notable footnotes:
  • F1: Grant occurred prior to issuer registration in the IPO (reported under Rule 16a-2(a)).
  • F2: Reorganization award delivering Class A Common Stock/Common Units and Class C Common Stock.
  • F3: RSUs — each converts to one share; vest in two substantially equal installments on the 3rd and 4th anniversaries of May 21, 2026.
  • F4–F7: Stock option grants with full vesting on Jan 1 of 2027, 2028, 2029 and 2030 (as applicable).
• Filing timeliness: Form 4 was filed May 26, 2026 for transactions on May 19 and May 21 — more than two business days after those transactions; investors may review the filing for any late-reporting notes.

Context

• These entries are awards/grants (code A) rather than purchases or sales; reported $0.00 reflects grant/compensation value at issuance, not a market purchase price.
• The RSU award is a contingent right to receive shares that vests on future dates; the option/derivative grants have scheduled future vesting dates (see F3–F7). Such grants are compensation and do not by themselves indicate immediate buying or selling activity.